POSITIVE QUANTIFERON-TB GOLD TEST AND SEROCONVERSION OF QUNATIFERON-TB GOLD TEST IS ASSOCIATED WITH INCREASED RISK OF THE DEVELOPMENT OF ACTIVE TUBERCULOSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM A REAL-WORLD DATA OVER 20 YEARS
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ahn, G. Y. | - |
dc.contributor.author | Koo, B. S. | - |
dc.contributor.author | Son, D. | - |
dc.contributor.author | Kim, Y. J. | - |
dc.contributor.author | Kang, J. | - |
dc.contributor.author | Lee, T. H. | - |
dc.contributor.author | Kim, J. H. | - |
dc.contributor.author | Song, G. G. | - |
dc.contributor.author | Kim, T. H. | - |
dc.date.available | 2020-12-30T01:40:37Z | - |
dc.date.issued | 202006 | - |
dc.identifier.issn | 0003-4967 | - |
dc.identifier.issn | 1468-2060 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/43408 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.title | POSITIVE QUANTIFERON-TB GOLD TEST AND SEROCONVERSION OF QUNATIFERON-TB GOLD TEST IS ASSOCIATED WITH INCREASED RISK OF THE DEVELOPMENT OF ACTIVE TUBERCULOSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS FROM A REAL-WORLD DATA OVER 20 YEARS | - |
dc.type | Conference | - |
dc.identifier.doi | 10.1136/annrheumdis-2020-eular.5959 | - |
dc.citation.title | ANNALS OF THE RHEUMATIC DISEASES | - |
dc.citation.startPage | 1242 | - |
dc.citation.endPage | 1242 | - |
dc.citation.conferenceName | Annual European Congress of Rheumatology (EULAR) 2020 | - |
dc.citation.conferencePlace | 영국 | - |
dc.citation.conferencePlace | ELECTR NETWORK | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.